Nanodrugs for the treatment of ischemic stroke: A systematic review
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessAttribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/Tarih
2023Yazar
Ruscu, MihaiCercel, Andreea
Kılıç, Ertuğrul
Çatalın, Boğdan
Gresita, Andrei
Hermann, Dirk M.
Albu, Carmen Valeria
Popa-Wagner, Aurel
Üst veri
Tüm öğe kaydını gösterKünye
Ruscu, M., Cercel, A., Kılıç, E., Çatalın, B., Gresita, A., Hermann, D. M. ... Popa-Wagner, A. (2023). Nanodrugs for the treatment of ischemic stroke: A systematic review. International Journal of Molecular Sciences, 24(13). https://dx.doi.org/10.3390/ijms241310802Özet
Ischemic stroke, a significant neurovascular disorder, currently lacks effective restorative medication. However, recently developed nanomedicines bring renewed promise for alleviating ischemia’s effects and facilitating the healing of neurological and physical functions. The aim of this systematic review was to evaluate the efficacy of nanotherapies in animal models of stroke and their potential impact on future stroke therapies. We also assessed the scientific quality of current research focused on nanoparticle-based treatments for ischemic stroke in animal models. We summarized the effectiveness of nanotherapies in these models, considering multiple factors such as their anti-inflammatory, antioxidant, and angiogenetic properties, as well as their safety and biodistribution. We conclude that the application of nanomedicines may reduce infarct size and improve neurological function post-stroke without causing significant organ toxicity.